Regardless of a woman’s smoking status, her BMI or whether she has any cardiovascular comorbidities, giving birth to at least one child raises her risk of developing heart disease or stroke by 16 percent, according to research out of Tongji Medical College in Wuhan, China.

Women who experience false-positive mammograms are at an increased risk of breast cancer for more than a decade, according to new research published in the British Journal of Cancer.

CMS wants to take a closer look at the financial relationships of accrediting organizations (AOs) that survey Medicare-certified healthcare providers.

The severity of left ventricular dysfunction at baseline didn’t appear to impact survival after transcatheter aortic valve replacement (TAVR) in a substudy of patients with low-flow, low-gradient (LFLG) aortic stenosis, suggesting TAVR is an acceptable treatment in this high-risk population.

Researchers from the University of Adelaide in Australia have developed a biopsy imaging needle that could help surgeons identify at-risk brain blood vessels during neurosurgery and avoid fatal cerebral bleeding, according to research published in the journal Science Advances.

A hospital-based breast imaging clinic implemented a real-time location system (RTLS) to track its workflow, learning important information that will lead to better patient care moving forward.

Outpatient centers across three states may have upcoded patients from stable angina to unstable angina to mask their use of inappropriate percutaneous coronary intervention (PCI), according to a report published Dec. 17 in JAMA Internal Medicine.

AI is expected to have a big impact on the way people gain access to healthcare services, according to the 2018 Health Trends report published by Stanford Medicine.

Popular anti-diabetes drug metformin could have positive implications for heart failure patients, too, according to a recent study that found the medication reduced left ventricular stiffness in mice with heart failure with preserved ejection fraction (HFpEF).

Women with false-positive results from screening mammography had twice the risk of being diagnosed with a screen-detected or interval breast cancer for more than a decade after screening compared to those with negative results, according to research published online Dec. 19 in the British Journal of Cancer.